Clinical improvement in Job syndrome following administration of co-trimoxazole, omalizumab and inhaled tobramycin.
Sign Up to like & getrecommendations! Published in 2021 at "Advances in respiratory medicine"
DOI: 10.5603/arm.a2021.0079
Abstract: Established treatment regimens for the autosomal dominant hyperimmunoglobulin E syndrome, denominated Job syndrome, are lacking. Thus, Job syndrome still exerts a dramatic impact on patients' quality of life. Our aim was to present safety and… read more here.
Keywords: trimoxazole omalizumab; job; job syndrome; inhaled tobramycin ... See more keywords